Marc Buyse
About
In The Last Decade
Marc Buyse
388 papers receiving 28.2k citations
Hit Papers
Peers
Comparison fields: 5 of 196
- Oncology 15.5k
- Pulmonary and Respiratory Medicine 7.7k
- Cancer Research 6.3k
- Molecular Biology 5.4k
- Surgery 4.9k
Countries citing papers authored by Marc Buyse
This map shows the geographic impact of Marc Buyse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Buyse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Buyse more than expected).
Fields of papers citing papers by Marc Buyse
This network shows the impact of papers produced by Marc Buyse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Buyse. The network helps show where Marc Buyse may publish in the future.
Co-authorship network of co-authors of Marc Buyse
This figure shows the co-authorship network connecting the top 25 collaborators of Marc Buyse. A scholar is included among the top collaborators of Marc Buyse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Buyse. Marc Buyse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 32 | |
| 7 | 5 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 3 | |
| 11 | A causal-inference approach for the validation of surrogate endpoints based on information theory and sensitivity analysis | 1 |
| 12 | 294 | |
| 13 | Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen breakdown → | 581 |
| 14 | Critical issues in colorectal cancer trial design | 0 |
| 15 | Comprehensive molecular analysis of several prognostic signatures using molecular indices related to hallmarks of breast cancer: proliferation index appears to be the most significant component of all signatures | 2 |
| 16 | 304 | |
| 17 | FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study breakdown → | 2290 |
| 18 | 23 | |
| 19 | Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer | 162 |
| 20 | Cyclophosphamide Plus Cisplatin Versus Cyclophosphomide, Doxorubicin, and Cisplatin Chemotherapy of Ovarian-carcinoma - a Metaanalysis | 107 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.